Max Zeller Soehne AG   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Romanshorn Switzerland (1864)
Status: No NME R&D (1864)

Organization Overview

First Clinical Trial
2008
NCT00862225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Max Zeller Soehne AG